Viewing Study NCT02259868


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2025-12-28 @ 3:37 PM
Study NCT ID: NCT02259868
Status: COMPLETED
Last Update Posted: 2018-08-31
First Post: 2014-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module